Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester

Journal of Bioenergetics and Biomembranes

Volumn 44, Issue 1, 2012, Pages 117-125

  Tang, Zhenjie ^a   Yuan, Shuqiang ^a,b   Hu, Yumin ^a   Zhang, Hui ^b   Wu, Wenjing ^a   Zeng, Zhaolei ^a   Yang, Jing ^a   Yun, Jingping ^a   Xu, Ruihua ^a   Huang, Peng ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

3 Bromopyruvate; Colon cancer; GAPDH; Metastasis; Warburg effect

Indexed keywords

3 BROMOPYRUVATE PROPYL ESTER; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL DEATH; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEXOKINASE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PYRUVATES;

EID: 84862777922     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-012-9420-9     Document Type: Article

References (32)

1. Achanta G, Sasaki R, Feng L, Carew JS, Lu W, Pelicano H, Keating MJ, Huang P (2005) Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J 24:3482-3492 (Pubitemid 41486785)
2. Akers LJ, Fang W, Levy AG, Franklin AR, Huang P, Zweidler-McKay PA (2011) Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycin. Leuk Res 35:814-820
3. Banas T, Gontero B, Drews VL, Johnson SL, Marcus F, Kemp RG (1988) Reactivity of the thiol groups of Escherichia coli phosphofructo-1-kinase. Biochim Biophys Acta 957:178-184
4. Borthwick EB, Connell SJ, Tudor DW, Robins DJ, Shneier A, Abell C, Coggins JR (1995) Escherichia coli dihydrodipicolinate synthase: characterization of the imine intermediate and the product of bromopyruvate treatment by electrospray mass spectrometry. Biochem J 305(Pt 2):521-524
5. Chen Z, Lu W, Garcia-Prieto C, Huang P (2007) The Warburg effect and its cancer therapeutic implications. J Bioenerg Biomembr 39:267-274 (Pubitemid 47619379)
6. Chen Z, Zhang H, Lu W, Huang P (2009) Role of mitochondriaassociated hexokinase II in cancer cell death induced by 3-bromopyruvate. Biochim Biophys Acta 1787:553-560
7. Cini C, Foppoli C, De Marco C (1978) On the product of the reaction between cysteamine and 3-bromopyruvate. Ital J Biochem 27:233-246
8. Epner DE, Coffey DS (1996) There aremultiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Prostate 28:372-378 (Pubitemid 26187721)
9. Epner DE, Partin AW, Schalken JA, Isaacs JT, Coffey DS (1993) Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res 53:1995-1997 (Pubitemid 23145716)
10. Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Vossen JA, Tchernyshyov I, Cole RN, Syed LH, Rao PP, Ota S, Vali M (2009) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res 29:4909-4918
11. Honda T, Tokushige M (1985) Active site-directed modification of tryptophanase by 3-bromopyruvate. J Biochem 97:851-857 (Pubitemid 15148392)
12. Kirley JW, Day RA (1985) Irreversible inhibition of carbonic anhydrase by the carbon dioxide analog cyanogen. Biochem Biophys Res Commun 126:457-463 (Pubitemid 15173579)
13. Ko YH, Pedersen PL, Geschwind JF (2001) Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 173:83-91 (Pubitemid 32907513)
14. Levy AG, Zage PE, Akers LJ, Ghisoli ML, Chen Z, Fang W, Kannan S, Graham T, Zeng L, Franklin AR, Huang P, Zweidler-McKay PA (2010) The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma. Invest New Drugs 2010 Oct 5 [Epub ahead of print]
15. Lowe PN, Perham RN (1984) Bromopyruvate as an active-site-directed inhibitor of the pyruvate dehydrogenase multienzyme complex from Escherichia coli. Biochemistry 23:91-97
16. Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol 19:17-24
17. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (2006) p53 regulates mitochondrial respiration. Science 312:1650-1653 (Pubitemid 43902663)
18. Mikuriya K, Kuramitsu Y, Ryozawa S, Fujimoto M, Mori S, Oka M, Hamano K, Okita K, Sakaida I, Nakamura K (2007) Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol 30:849-855
19. Nicholls C, Li H, Liu JP (2011) GAPDH: a common enzyme with uncommon functions. Clin Exp Pharmacol Physiol
20. Pedersen PL (2007)Warburg,me and Hexokinase 2:multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39:211-222
21. Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633-4646 (Pubitemid 44187614)
22. Persons DA, Schek N, Hall BL, Finn OJ (1989) Increased expression of glycolysis-associated genes in oncogene-transformed and growthaccelerated states. Mol Carcinog 2:88-94 (Pubitemid 19201852)
23. Rondinelli RH, Epner DE, Tricoli JV (1997) Increased glyceraldehyde-3- phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1:66-72 (Pubitemid 127537989)
24. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, Rehrauer H, Laczko E, Kurowski MA, Bujnicki JM, Menigatti M, Luz J, Ranalli TV, Gomes V, Pastorelli A, Faggiani R, Anti M, Jiricny J, Clevers H, Marra G (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5:1263-1275
25. Schek N, Hall BL, Finn OJ (1988) Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Cancer Res 48:6354-6359
26. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S (1987) Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 47:5616-5619 (Pubitemid 18046754)
27. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033
28. Warburg O (1956a) On respiratory impairment in cancer cells. Science 124:269-270
29. Warburg O (1956b) On the origin of cancer cells. Science 123:309-314
30. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P (2005a) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65:613-621
31. Xu RH, Pelicano H, Zhang H, Giles FJ, Keating MJ, Huang P (2005b) Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells. Leukemia 19:2153-2158 (Pubitemid 41741609)
32. Yoshida H, Wood HG (1978) Crystalline pyruvate, phosphate dikinase from Bacteroides symbiosus. Modification of essential histidyl residues and bromopyruvate inactivation. J Biol Chem 253:7650-7655